Soluble VE-cadherin and VE-cadherin Antibody in Sclerodermic Sclerosis

Clinical trial NCT02212249 · COMPLETED

Trial details

NCT number: NCT02212249
Sponsor: University Hospital, Grenoble
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Primary Raynaud Disease Systemic Sclerosis

Start date: 2014-05-01
Primary completion: 2016-03-01
Enrollment: 85

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.